Atorvastatin intra-subject Variability [Study As­sess­ment]

posted by ElMaestro  – Belgium?, 2017-09-26 12:51  – Posting: # 17830
Views: 3,416

Hi Amira,

Chance?
Better assay?
Design differences?
Lesser within-batch variability (-ies) than in the studies you compare to?

I could be wrong, but...
Best regards,
ElMaestro

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,871 posts in 4,212 threads, 1,364 registered users;
online 11 (0 registered, 11 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 12:22 CEST

A drug is not bad. A drug is a chemical compound.
The problem comes in when people who take drugs treat them
like a license to behave like an asshole.    Frank Zappa

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5